PVH
RDY icon

Psagot Value Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

Psagot Value Holdings’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$28K – 446
2023
Q4 		$28K Hold
2,000
– – 0.01% 296
2023
Q3 		$26K Hold
2,000
– – 0.01% 268
2023
Q2 		$25K Hold
2,000
– – 0.01% 270
2023
Q1 		$22K Buy
+2,000
New +$21.6K 0.01% 281

Other funds holding RDY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Psagot Value Holdings's RDY Position: Q1 2024 in Review

Psagot Value Holdings sold out of Dr. Reddy's Laboratories (RDY) in Q1 2024, closing a stake of 2,000 shares — an estimated $28K sold.

Psagot Value Holdings first reported a position in RDY in Q1 2023 and held it in 4 quarters. The position peaked at $28K in Q4 2023. 230 funds tracked by Wall St. Rank hold RDY as of Q1 2024.

  • Psagot Value Holdings reported no remaining Dr. Reddy's Laboratories position as of Q1 2024 after selling out during the quarter.
  • Psagot Value Holdings sold 2,000 Dr. Reddy's Laboratories shares in Q1 2024, an estimated $28K.
  • Psagot Value Holdings first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 4 quarters.
  • Psagot Value Holdings's Dr. Reddy's Laboratories position peaked at $28K in Q4 2023.
  • 230 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2024.

Based on Psagot Value Holdings's 13F filing for Q1 2024, filed 15 May 2024.